阿克斯生物科學公司
US ˙ NYSE ˙ US03969F1093

SecurityRCUS / Arcus Biosciences, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership119,429 shares
Latest Disclosed Value $ 972,152
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series reports 31.46% increase in ownership of RCUS / Arcus Biosciences, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 119,429 shares of Arcus Biosciences, Inc. (US:RCUS) valued at $972,152 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 90,847 shares of Arcus Biosciences, Inc.. This represents a change in shares of 31.46% during the quarter. The current value of the position is $2,769,559 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Arcus Biosciences EC US03969F1093 119,429 28,582 31.46 972 36.33 0.0218
2025-05-28 2025-03-31 NP Arcus Biosciences EC US03969F1093 90,847 0 0.00 713 -47.26 0.0171
2025-02-25 2024-12-31 NP Arcus Biosciences EC US03969F1093 90,847 -14,406 -13.69 1,353 -15.97 0.0295
2024-11-26 2024-09-30 NP Arcus Biosciences EC US03969F1093 105,253 4,999 4.99 1,609 5.44 0.0304
2024-08-26 2024-06-30 NP Arcus Biosciences EC US03969F1093 100,254 4,008 4.16 1,527 -16.02 0.0311
2024-05-28 2024-03-31 NP Arcus Biosciences EC US03969F1093 96,246 0 0.00 1,817 -1.14 0.0379
2024-02-26 2023-12-31 NP Arcus Biosciences EC US03969F1093 96,246 6,372 7.09 1,838 13.95 0.0392
2023-11-28 2023-09-30 NP Arcus Biosciences EC US03969F1093 89,874 -2,181 -2.37 1,613 -13.70 0.0421
2023-08-25 2023-06-30 NP Arcus Biosciences EC US03969F1093 92,055 11,024 13.60 1,870 26.45 0.0443
2023-05-26 2023-03-31 NP Arcus Biosciences EC US03969F1093 81,031 0 0.00 1,478 -11.76 0.0394
2023-02-24 2022-12-31 NP Arcus Biosciences EC US03969F1093 81,031 -915 -1.12 1,676 -21.84 0.0461
2022-11-25 2022-09-30 NP Arcus Biosciences EC US03969F1093 81,946 2,601 3.28 2,144 6.62 0.0614
2022-08-25 2022-06-30 NP Arcus Biosciences EC US03969F1093 79,345 9,290 13.26 2,011 -9.05 0.0555
2022-05-26 2022-03-31 NP Arcus Biosciences EC US03969F1093 70,055 1,356 1.97 2,211 -20.50 0.0515
2022-02-25 2021-12-31 NP Arcus Biosciences EC US03969F1093 68,699 982 1.45 2,780 17.75 0.0603
2021-11-24 2021-09-30 NP Arcus Biosciences EC US03969F1093 67,717 -4,739 -6.54 2,361 18.70 0.0520
2021-08-26 2021-06-30 NP Arcus Biosciences EC US03969F1093 72,456 7,965 12.35 1,990 9.89 0.0427
2021-05-27 2021-03-31 NP Arcus Biosciences EC US03969F1093 64,491 -3,567 -5.24 1,811 2.49 0.0411
2021-02-25 2020-12-31 NP Arcus Biosciences EC US03969F1093 68,058 0 0.00 1,767 51.46 0.0453
2020-11-25 2020-09-30 NP Arcus Biosciences EC US03969F1093 68,058 12,051 21.52 1,167 -15.81 0.0374
2020-08-27 2020-06-30 NP Arcus Biosciences EC US03969F1093 56,007 2,223 4.13 1,386 85.66 0.0453
2020-06-01 2020-03-31 NP Arcus Biosciences EC US03969F1093 53,784 4,165 8.39 747 48.90 0.0305
2020-02-27 2019-12-31 NP Arcus Biosciences EC 03969F109 49,619 2,539 5.39 501 17.06 0.0151
2019-11-27 2019-09-30 NP Arcus Biosciences EC US03969F1093 47,080 47,080 428 0.0142
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.